SCHEMBL19769027

SCHEMBL19769027

CC(C)c1ncccc1C=NO

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.49
▸ FGF23 Q9GZV9 2/20 0.49
▸ HPGD P15428 5/20 0.40
▸ TSHR P16473 2/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ ALOX12 P18054 1/20 0.39
▸ LMNA P02545 4/20 0.36
▸ HTT P42858 2/20 0.36
▸ MAPT P10636 2/20 0.35
▸ USP2 O75604 2/20 0.35
▸ RIPK1 Q13546 1/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19880469 1.00 ALDH1A1 (0.49) ALDH1A1FGF23HPGDTSHRMAPK1
SCHEMBL23492891 0.82 FGF23 (0.42) ALDH1A1FGF23HPGDTSHRMAPK1
SCHEMBL20621419 0.78 FGF23 (0.41) ALDH1A1FGF23HPGDTSHRMAPK1
SCHEMBL21173560 0.77 ALDH1A1 (0.33) ALDH1A1FGF23HPGDTSHRMAPK1
SCHEMBL29335083 0.77 ALDH1A1 (0.47) ALDH1A1FGF23HPGDTSHRMAPK1
SCHEMBL2120978 0.77 FGF23 (0.55) ALDH1A1FGF23HPGDTSHRMAPK1
SCHEMBL31046315 0.77 ALDH1A1 (0.47) ALDH1A1FGF23HPGDTSHRMAPK1
SCHEMBL3927387 0.77 FGF23 (0.55) ALDH1A1FGF23HPGDTSHRMAPK1
SCHEMBL17063992 0.76 ALDH1A1 (0.44) ALDH1A1FGF23HPGDTSHRMAPK1
SCHEMBL17063991 0.76 ALDH1A1 (0.44) ALDH1A1FGF23HPGDTSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9896432-B2 Somatostatin modulators and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2018-02-20 — — US disclosed
US-20180016252-A1 SOMATOSTATIN MODULATORS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2018-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180016252-A1 SOMATOSTATIN MODULATORS AND USES THEREOF SSTR5, SSTR2, SSTR4 ALDH1A1 4626/4885FGF23 194/4885HPGD 1517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback